Funding Alert

Medtech platform Yostra Labs raises Rs 4 crore in its seed round of funding from IAN and others

• ByStartupStory     |    August 16, 2022

Yostra Labs, a medtech firm, has secured Rs 4 crore in a seed round sponsored by the Indian Angel Network (IAN), Impact Innovators and Entrepreneurs Foundation (Villgro Innovations Foundation), and the Centre for Cellular and Molecular Platform.

The company creates tools to assist people with chronic illnesses in better managing their conditions. The money raised will go into expanding the internal sales and marketing team, expanding the company’s market reach, commercializing the product line, increasing manufacturing, streamlining the bill of materials, and scaling up manufacturing.

Venkataraman KNK, Lead Investor at IAN, said, “With a focus on diabetes neuropathy, Yostra develops a portfolio of patented treatments that can prevent problems and improve the quality of life for diabetics. This investment from IAN and co-investors will assist Yostra to establish a business that is viable while producing social impact.”

NEURO TOUCH, the company’s main product, is a complete point-of-care screening tool for small and large fiber peripheral neuropathy that aids doctors in the diagnosis of diabetic neuropathy. For the treatment of chronic wounds like diabetic foot ulcers, VELOX Care is a cutting-edge solution in wound care.

Yostra Labs says that over 40,000 people have been tested using their equipment in India’s clinics, commercial and public hospitals, and diagnostic facilities.

About Yostra Labs

Yostra, a healthcare technology company, was founded in 2014 by Vinayak Nandalike, Mohan Rao, Sanjay Sharma, and Maruthy. Yostra pioneers clever ideas to improve healthcare for the developing world’s price-conscious population. This Bengaluru-based company sells items like Kadam, a ground-breaking therapeutic gadget to speed up the healing of chronic wounds, and Neuro Touch, a point-of-care screening tool for peripheral neuropathy.

 

Follow Startup Story